Cargando…
Bioinformatic Analysis Reveals GSG2 as a Potential Target for Breast Cancer Therapy
OBJECTIVE: To explore the potential role of GSG2 in breast cancer progression. METHODS: The mRNA expression, DNA copy number and clinical data used in this study were obtained from the TCGA data portal. The copy number variations (CNVs) thresholds were determined according to the set of discrete cop...
Autores principales: | Ye, Zheng, Zhang, Zhaoyu, Fang, Lijiao, Tian, Daiquan, Liu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874749/ https://www.ncbi.nlm.nih.gov/pubmed/33817208 http://dx.doi.org/10.1515/biol-2019-0078 |
Ejemplares similares
-
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
por: Hermawan, Adam, et al.
Publicado: (2022) -
Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo
por: Yu, Feng, et al.
Publicado: (2020) -
GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer
por: Huang, Yan, et al.
Publicado: (2021) -
GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12)
por: Chen, Yuhao, et al.
Publicado: (2020) -
High-affinity consensus binding of target RNAs by the STAR/GSG proteins GLD-1, STAR-2 and Quaking
por: Carmel, Andrew B, et al.
Publicado: (2010)